Jenburkt Pharmaceuticals (BOM:524731) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524731 Jenburkt Pharmaceuticals Ltd BOM:524731
82 GF Score
Price ₹978.00
GF Value ₹1,149.73
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jenburkt Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:524731
82GF Score
Jenburkt Pharmaceuticals Ltd BOM:524731
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jenburkt Pharmaceuticals (BOM:524731) Overvalued in 2026?

Based on GuruFocus' analysis, Jenburkt Pharmaceuticals stock appears to be undervalued. The current stock price of ₹978.00 is trading 14.9% below its estimated GF Value™ of ₹1,149.73. GuruFocus considers Jenburkt Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:524731:

  • Short Ratio:
  • GF Value™: ₹1,149.73 vs. price of ₹978.00 (14.9% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the BOM:524731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jenburkt Pharmaceuticals Business Description

Other Exchanges JENBURPH:India
Address 93, Jayprakash Road, Nirmala Apartments, Andheri (West, Mumbai, MH, IND, 400058
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.
82GF Score

Get the complete analysis for BOM:524731

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹978.00
Price
₹1,149.73
GF Value